English

CHINA BIOPHARMA, INC.

EDGAR

Quarterly report (10-Q) · filed 2009-05-13

35 filing records in this dataset, filed from 2002-10-28 to 2009-05-13. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

0 USD

2009-03-31 · USD

Exact inputs and evidence

Revenue: 0 USD Source

Operating cash flow

368 thousand USD

2009-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 368336 USD Source

Free cash flow

368 thousand USD

2009-03-31 · USD

Exact inputs and evidence

Operating Cash Flow: 368336 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 346 thousand USD 2009-03-31 Source
Exact value

345899 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2009-05-13.

Financial data available through: 2008-12-31.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2008-12-31
Operating income: 6 of 11 periods available· newest 2008-12-31
Net income: 7 of 11 periods available· newest 2008-12-31
Operating cash flow: 7 of 11 periods available· newest 2008-12-31
Capital expenditure: 6 of 11 periods available· newest 2008-12-31
Total assets: 6 of 11 periods available· newest 2008-12-31
Total liabilities: 3 of 11 periods available· newest 2008-12-31
Current assets: 6 of 11 periods available· newest 2008-12-31
Current liabilities: 6 of 11 periods available· newest 2008-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2008-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+704.6%

Prior period

USD 688,705

2007-01-01 – 2007-12-31
Current period

USD 5.54 million

2008-01-01 – 2008-12-31

Exact inputs and evidence

5541317 − 688705 = 4852612 USD

688705 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
5541317 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · CHINA BIOPHARMA, INC. · 2008-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Year-over-year change in Revenue: 4852612 USD Concept: fundies:Revenue Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 5541317 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#5985 Input fundies:Revenue: 688705 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#5985
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 722,994

Prior period

−USD 1.65 million

2007-01-01 – 2007-12-31
Current period

−USD 930,087

2008-01-01 – 2008-12-31

Exact inputs and evidence

-930087 − -1653081 = 722994 USD

-1653081 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
-930087 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · CHINA BIOPHARMA, INC. · 2008-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Year-over-year change in Net income: 722994 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -930087 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#10058 Input fundies:NetIncome: -1653081 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#10058
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 331,583

Prior period

−USD 1.04 million

2007-01-01 – 2007-12-31
Current period

−USD 710,607

2008-01-01 – 2008-12-31

Exact inputs and evidence

-710607 − -1042190 = 331583 USD

-1042190 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
-710607 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · CHINA BIOPHARMA, INC. · 2008-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Year-over-year change in Operating cash flow: 331583 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -710607 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#10520 Input fundies:OperatingCashFlow: -1042190 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#10520
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-37.7%

Prior period

USD 16,364

2007-01-01 – 2007-12-31
Current period

USD 10,199

2008-01-01 – 2008-12-31

Exact inputs and evidence

10199 − 16364 = -6165 USD

16364 USD · 2007-01-01 – 2007-12-31
Inspect prior input Prior source
10199 USD · 2008-01-01 – 2008-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · CHINA BIOPHARMA, INC. · 2008-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Year-over-year change in Capital expenditure: -6165 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 10199 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#10608 Input fundies:CapitalExpenditure: 16364 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#10608
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2008 2008-01-01 – 2008-12-31

Revenue USD 5.54 million 100% of revenue
Cost of revenue USD 5.33 million 96% of revenue
Operating expenses USD 1.17 million 21% of revenue
Operating income −USD 964,169 −17% of revenue
Tax, interest and other Derived −USD 34,082 −0.6% of revenue
Net income −USD 930,087 −17% of revenue

Cash

Operating cash flow −USD 710,607 −13% of revenue
Capital expenditure USD 10,199 0.2% of revenue
Free cash flow Derived −USD 720,806 −13% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2003 Operating loss: operating costs were 344% of revenue.
2004 Operating loss: operating costs were 558% of revenue.
2005 Operating loss: operating costs were 818% of revenue.
2006 Operating loss: operating costs were 405% of revenue.
2007 Operating loss: operating costs were 340% of revenue.
2008 Operating loss: operating costs were 117% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2003 2003-01-01 – 2003-12-31	437361	1503180 Derived	-1065819	-1977 Derived	-1063842	-1019332 Derived	Source 2003-01-01 – 2003-12-31: 437361 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -1065819 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -1063842 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -986089 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 33243 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	312899	1746230 Derived	-1433331	12291 Derived	-1445622	-1389839 Derived	Source 2004-01-01 – 2004-12-31: 312899 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: -1433331 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: -1445622 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: -1377419 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 12420 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	380519	3114335 Derived	-2733816	107500 Derived	-2841316	-1713620 Derived	Source 2005-01-01 – 2005-12-31: 380519 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: -2733816 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: -2841316 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: -1662834 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 50786 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	1202763	4865857 Derived	-3663094	1063110 Derived	-4726204	2238546 Derived	Source 2006-01-01 – 2006-12-31: 1202763 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -3663094 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -4726204 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: 2256895 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 18349 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	688705	2341412 Derived	-1652707	374 Derived	-1653081	-1058554 Derived	Source 2007-01-01 – 2007-12-31: 688705 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -1652707 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -1653081 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -1042190 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 16364 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	5541317	6505486 Derived	-964169	-34082 Derived	-930087	-720806 Derived	Source 2008-01-01 – 2008-12-31: 5541317 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -964169 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -930087 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: -710607 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 10199 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 5.5M 2008

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Revenue	437361	Revenue: 437361 Open source
20042004-12-31	Revenue	312899	Revenue: 312899 Open source
20052005-12-31	Revenue	380519	Revenue: 380519 Open source
20062006-12-31	Revenue	1202763	Revenue: 1202763 Open source
20072007-12-31	Revenue	688705	Revenue: 688705 Open source
20082008-12-31	Revenue	5541317	Revenue: 5541317 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

704.6% 2008

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20032003-12-31	Year over year	No prior comparable period	Revenue: 437361 Open source
20042004-12-31	Year over year	-28.5%	Revenue: 312899 Open source Revenue: 437361 Open source
20052005-12-31	Year over year	21.6%	Revenue: 380519 Open source Revenue: 312899 Open source
20062006-12-31	Year over year	216.1%	Revenue: 1202763 Open source Revenue: 380519 Open source
20072007-12-31	Year over year	-42.7%	Revenue: 688705 Open source Revenue: 1202763 Open source
20082008-12-31	Year over year	704.6%	Revenue: 5541317 Open source Revenue: 688705 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -17.4% 2008

Net margin -16.8% 2008

Free cash flow margin -13% 2008

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20032003-12-31	Operating margin	-243.7%	Operating Income: -1065819 Open source Revenue: 437361 Open source
20042004-12-31	Operating margin	-458.1%	Operating Income: -1433331 Open source Revenue: 312899 Open source
20052005-12-31	Operating margin	-718.4%	Operating Income: -2733816 Open source Revenue: 380519 Open source
20062006-12-31	Operating margin	-304.6%	Operating Income: -3663094 Open source Revenue: 1202763 Open source
20072007-12-31	Operating margin	-240%	Operating Income: -1652707 Open source Revenue: 688705 Open source
20082008-12-31	Operating margin	-17.4%	Operating Income: -964169 Open source Revenue: 5541317 Open source
20032003-12-31	Net margin	-243.2%	Net Income: -1063842 Open source Revenue: 437361 Open source
20042004-12-31	Net margin	-462%	Net Income: -1445622 Open source Revenue: 312899 Open source
20052005-12-31	Net margin	-746.7%	Net Income: -2841316 Open source Revenue: 380519 Open source
20062006-12-31	Net margin	-392.9%	Net Income: -4726204 Open source Revenue: 1202763 Open source
20072007-12-31	Net margin	-240%	Net Income: -1653081 Open source Revenue: 688705 Open source
20082008-12-31	Net margin	-16.8%	Net Income: -930087 Open source Revenue: 5541317 Open source
20032003-12-31	Free cash flow margin	-233.1%	Revenue: 437361 Open source Operating Cash Flow: -986089 Open source Capital Expenditure: 33243 Open source
20042004-12-31	Free cash flow margin	-444.2%	Revenue: 312899 Open source Operating Cash Flow: -1377419 Open source Capital Expenditure: 12420 Open source
20052005-12-31	Free cash flow margin	-450.3%	Revenue: 380519 Open source Operating Cash Flow: -1662834 Open source Capital Expenditure: 50786 Open source
20062006-12-31	Free cash flow margin	186.1%	Revenue: 1202763 Open source Operating Cash Flow: 2256895 Open source Capital Expenditure: 18349 Open source
20072007-12-31	Free cash flow margin	-153.7%	Revenue: 688705 Open source Operating Cash Flow: -1042190 Open source Capital Expenditure: 16364 Open source
20082008-12-31	Free cash flow margin	-13%	Revenue: 5541317 Open source Operating Cash Flow: -710607 Open source Capital Expenditure: 10199 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -710.6K 2008

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Operating cash flow	-986089	Operating Cash Flow: -986089 Open source
20042004-12-31	Operating cash flow	-1377419	Operating Cash Flow: -1377419 Open source
20052005-12-31	Operating cash flow	-1662834	Operating Cash Flow: -1662834 Open source
20062006-12-31	Operating cash flow	2256895	Operating Cash Flow: 2256895 Open source
20072007-12-31	Operating cash flow	-1042190	Operating Cash Flow: -1042190 Open source
20082008-12-31	Operating cash flow	-710607	Operating Cash Flow: -710607 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -720.8K 2008

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20032003-12-31	Free cash flow	-1019332	Operating Cash Flow: -986089 Open source Capital Expenditure: 33243 Open source
20042004-12-31	Free cash flow	-1389839	Operating Cash Flow: -1377419 Open source Capital Expenditure: 12420 Open source
20052005-12-31	Free cash flow	-1713620	Operating Cash Flow: -1662834 Open source Capital Expenditure: 50786 Open source
20062006-12-31	Free cash flow	2238546	Operating Cash Flow: 2256895 Open source Capital Expenditure: 18349 Open source
20072007-12-31	Free cash flow	-1058554	Operating Cash Flow: -1042190 Open source Capital Expenditure: 16364 Open source
20082008-12-31	Free cash flow	-720806	Operating Cash Flow: -710607 Open source Capital Expenditure: 10199 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

139.4% 2008

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2003-12-31	Liabilities / assets	Not reported	Total Assets: 1525322 Open source
2004-12-31	Liabilities / assets	Not reported	Total Assets: 870800 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 607942 Open source
20062006-12-31	Liabilities / assets	123.5%	Total Liabilities: 9651250 Open source Total Assets: 7816016 Open source
20072007-12-31	Liabilities / assets	127.8%	Total Liabilities: 7980552 Open source Total Assets: 6245992 Open source
20082008-12-31	Liabilities / assets	139.4%	Total Liabilities: 7064407 Open source Total Assets: 5068272 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.62× 2008

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20032003-12-31	Current assets / current liabilities	0.74×	Current Assets: 835510 Open source Current Liabilities: 1127853 Open source
20042004-12-31	Current assets / current liabilities	0.23×	Current Assets: 324177 Open source Current Liabilities: 1418647 Open source
20052005-12-31	Current assets / current liabilities	0.2×	Current Assets: 452383 Open source Current Liabilities: 2271227 Open source
20062006-12-31	Current assets / current liabilities	1.02×	Current Assets: 5964897 Open source Current Liabilities: 5849872 Open source
20072007-12-31	Current assets / current liabilities	0.8×	Current Assets: 4739603 Open source Current Liabilities: 5896792 Open source
20082008-12-31	Current assets / current liabilities	0.62×	Current Assets: 3571249 Open source Current Liabilities: 5746310 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2002 2002-01-01 – 2002-12-31	−USD 56,526 Exact value Exact value: -56526 USD 2002-01-01 – 2002-12-31: -56526 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA BIOPHARMA, INC. · 2002-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Net Income: -56526 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -56526 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001172665-04-000055.txt#627 The citation records this snapshot. The page link may show a newer release later.	−USD 86 Exact value Exact value: -86 USD 2002-01-01 – 2002-12-31: -86 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA BIOPHARMA, INC. · 2002-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Operating Cash Flow: -86 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -86 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001172665-04-000055.txt#637 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2003 2003-01-01 – 2003-12-31	−USD 1.06 million Exact value Exact value: -1063842 USD 2003-01-01 – 2003-12-31: -1063842 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA BIOPHARMA, INC. · 2003-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Net Income: -1063842 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1063842 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-05-009444.txt#1799 The citation records this snapshot. The page link may show a newer release later.	−USD 986,089 Exact value Exact value: -986089 USD 2003-01-01 – 2003-12-31: -986089 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA BIOPHARMA, INC. · 2003-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Operating Cash Flow: -986089 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -986089 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-05-009444.txt#1815 The citation records this snapshot. The page link may show a newer release later.	USD 33,243 Exact value Exact value: 33243 USD 2003-01-01 – 2003-12-31: 33243 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHINA BIOPHARMA, INC. · 2003-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Capital Expenditure: 33243 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 33243 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-05-009444.txt#1820 The citation records this snapshot. The page link may show a newer release later.	−USD 1.02 million Calculation and evidence -986089 − 33243 USD Exact free cash flow: -1019332 USD 2003-01-01 – 2003-12-31: -986089 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 33243 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHINA BIOPHARMA, INC. · 2003-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Free cash flow: -1019332 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -986089 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-05-009444.txt#1815 Input fundies:CapitalExpenditure: 33243 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-05-009444.txt#1820 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	−USD 1.45 million Exact value Exact value: -1445622 USD 2004-01-01 – 2004-12-31: -1445622 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA BIOPHARMA, INC. · 2004-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Net Income: -1445622 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1445622 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-06-012273.txt#1970 The citation records this snapshot. The page link may show a newer release later.	−USD 1.38 million Exact value Exact value: -1377419 USD 2004-01-01 – 2004-12-31: -1377419 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA BIOPHARMA, INC. · 2004-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Operating Cash Flow: -1377419 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1377419 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-06-012273.txt#1989 The citation records this snapshot. The page link may show a newer release later.	USD 12,420 Exact value Exact value: 12420 USD 2004-01-01 – 2004-12-31: 12420 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHINA BIOPHARMA, INC. · 2004-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Capital Expenditure: 12420 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12420 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-06-012273.txt#1995 The citation records this snapshot. The page link may show a newer release later.	−USD 1.39 million Calculation and evidence -1377419 − 12420 USD Exact free cash flow: -1389839 USD 2004-01-01 – 2004-12-31: -1377419 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 12420 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHINA BIOPHARMA, INC. · 2004-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Free cash flow: -1389839 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1377419 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-06-012273.txt#1989 Input fundies:CapitalExpenditure: 12420 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-06-012273.txt#1995 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	−USD 2.84 million Exact value Exact value: -2841316 USD 2005-01-01 – 2005-12-31: -2841316 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA BIOPHARMA, INC. · 2005-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Net Income: -2841316 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: -2841316 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-016748.txt#4183 The citation records this snapshot. The page link may show a newer release later.	−USD 1.66 million Exact value Exact value: -1662834 USD 2005-01-01 – 2005-12-31: -1662834 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA BIOPHARMA, INC. · 2005-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Operating Cash Flow: -1662834 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1662834 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-016748.txt#4555 The citation records this snapshot. The page link may show a newer release later.	USD 50,786 Exact value Exact value: 50786 USD 2005-01-01 – 2005-12-31: 50786 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHINA BIOPHARMA, INC. · 2005-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Capital Expenditure: 50786 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 50786 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-016748.txt#4643 The citation records this snapshot. The page link may show a newer release later.	−USD 1.71 million Calculation and evidence -1662834 − 50786 USD Exact free cash flow: -1713620 USD 2005-01-01 – 2005-12-31: -1662834 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 50786 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHINA BIOPHARMA, INC. · 2005-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Free cash flow: -1713620 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1662834 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-016748.txt#4555 Input fundies:CapitalExpenditure: 50786 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-016748.txt#4643 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 4.73 million Exact value Exact value: -4726204 USD 2006-01-01 – 2006-12-31: -4726204 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA BIOPHARMA, INC. · 2006-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Net Income: -4726204 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4726204 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-016751.txt#4634 The citation records this snapshot. The page link may show a newer release later.	USD 2.26 million Exact value Exact value: 2256895 USD 2006-01-01 – 2006-12-31: 2256895 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA BIOPHARMA, INC. · 2006-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Operating Cash Flow: 2256895 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 2256895 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-016751.txt#5077 The citation records this snapshot. The page link may show a newer release later.	USD 18,349 Exact value Exact value: 18349 USD 2006-01-01 – 2006-12-31: 18349 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHINA BIOPHARMA, INC. · 2006-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Capital Expenditure: 18349 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 18349 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-016751.txt#5165 The citation records this snapshot. The page link may show a newer release later.	USD 2.24 million Calculation and evidence 2256895 − 18349 USD Exact free cash flow: 2238546 USD 2006-01-01 – 2006-12-31: 2256895 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 18349 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHINA BIOPHARMA, INC. · 2006-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Free cash flow: 2238546 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 2256895 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-016751.txt#5077 Input fundies:CapitalExpenditure: 18349 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-016751.txt#5165 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 1.65 million Exact value Exact value: -1653081 USD 2007-01-01 – 2007-12-31: -1653081 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA BIOPHARMA, INC. · 2007-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Net Income: -1653081 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1653081 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#10058 The citation records this snapshot. The page link may show a newer release later.	−USD 1.04 million Exact value Exact value: -1042190 USD 2007-01-01 – 2007-12-31: -1042190 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA BIOPHARMA, INC. · 2007-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Operating Cash Flow: -1042190 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1042190 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#10520 The citation records this snapshot. The page link may show a newer release later.	USD 16,364 Exact value Exact value: 16364 USD 2007-01-01 – 2007-12-31: 16364 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHINA BIOPHARMA, INC. · 2007-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Capital Expenditure: 16364 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 16364 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#10608 The citation records this snapshot. The page link may show a newer release later.	−USD 1.06 million Calculation and evidence -1042190 − 16364 USD Exact free cash flow: -1058554 USD 2007-01-01 – 2007-12-31: -1042190 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 16364 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHINA BIOPHARMA, INC. · 2007-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Free cash flow: -1058554 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1042190 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#10520 Input fundies:CapitalExpenditure: 16364 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#10608 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 930,087 Exact value Exact value: -930087 USD 2008-01-01 – 2008-12-31: -930087 USD Inspect Net Income Open source Share or cite Citation for Net Income · CHINA BIOPHARMA, INC. · 2008-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Net Income: -930087 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -930087 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#10058 The citation records this snapshot. The page link may show a newer release later.	−USD 710,607 Exact value Exact value: -710607 USD 2008-01-01 – 2008-12-31: -710607 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · CHINA BIOPHARMA, INC. · 2008-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Operating Cash Flow: -710607 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -710607 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#10520 The citation records this snapshot. The page link may show a newer release later.	USD 10,199 Exact value Exact value: 10199 USD 2008-01-01 – 2008-12-31: 10199 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · CHINA BIOPHARMA, INC. · 2008-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Capital Expenditure: 10199 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10199 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#10608 The citation records this snapshot. The page link may show a newer release later.	−USD 720,806 Calculation and evidence -710607 − 10199 USD Exact free cash flow: -720806 USD 2008-01-01 – 2008-12-31: -710607 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 10199 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · CHINA BIOPHARMA, INC. · 2008-12-31 CHINA BIOPHARMA, INC. (edgar:1190132) Free cash flow: -720806 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T14:02:07Z Snapshot: 6830cde8e2588d07768f6ddda8d32852c82169000559b22e89ef5971bcae6f64 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1190132?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -710607 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#10520 Input fundies:CapitalExpenditure: 10199 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1190132/0001144204-09-017436.txt#10608 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

35 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001190132, 1190132, edgar:1190132

Also known as TECHEDGE INC

CHINA BIOPHARMA, INC.

Latest quarter

Revenue

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2008 2008-01-01 – 2008-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation